Blog
About

1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The state of regional therapy in the management of metastatic colorectal cancer to the liver.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Colorectal cancer (CRC) is one of the leading causes of cancer-related mortality in the United States. Most colorectal cancer patients die from advanced disease, and two-thirds of CRC deaths are due to liver metastases. Liver resection provides the best curative option for patients with colorectal liver metastases (CRLM), yet only 20% of those patients are eligible for liver metastases resection for curative intent. Loco-regional treatment of CRLM may provide additional benefits in terms of down-staging for resection and prolonged hepatic disease control. This review focusses on hepatic arterial infusion, radioembolization and chemoembolization.

          Related collections

          Author and article information

          Journal
          Expert Rev Anticancer Ther
          Expert review of anticancer therapy
          Informa UK Limited
          1744-8328
          1473-7140
          2016
          : 16
          : 2
          Affiliations
          [1 ] a Department of Medical Oncology , City of Hope National Medical Center , Duarte , CA , USA.
          10.1586/14737140.2016.1129277
          26652741

          Comments

          Comment on this article